There was one negative, the increased revenue did not translate into increased profits.
Slide 14 paints a very interesting picture.
Revenue + 25% - Good
Gross profit +24% - Good
NPATA + 10% - Not Good
There was a lot of leakage in S & M expenses, R & D (Ok with that - it is needed in their business) G & A and finance (understandable due to VIFOR acquisition).
I suspect that there will be some cost reduction occurring very soon in S & M to get Gross profit translating to NAPTA better.
HT1
Ann: CSL Half Year Results Announcement & Investor Presentation, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$263.95 |
Change
8.640(3.38%) |
Mkt cap ! $127.8B | |||
| Open | High | Low | Value | Volume |
| $258.12 | $264.81 | $257.91 | $311.0M | 1.182M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 833 | $263.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $263.98 | 30529 | 2 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |